Profile
John Dadurian worked as a Senior Director of Finance and Accounting at Albireo Pharma, Inc. from 2018 to 2021.
Former positions of John Dadurian
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Comptroller/Controller/Auditor | 31/10/2021 |
Experiences
Positions held
Connections
6
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- John Dadurian
